S.Biomedics (KOSDAQ: 304360) is a biopharmaceutical company specializing in the research and development of cell therapies for regenerative medicine.

Our two core platform technologies — TED and FECS™ — drive a pipeline of 7 programs, including 4 in clinical development, targeting intractable diseases such as Parkinson's disease and Critical Limb Ischemia. This work is grounded in a deep respect for life and a commitment to integrity, delivering treatment solutions where conventional medicine falls short.

Supported by an extensive global patent portfolio, we remain dedicated to advancing cell therapy from the ground up.

For more information, visit sbiomedics.com


S.BIOMEDICS

Org chart

Teams

Offices

S.BIOMEDICS

Org chart

Teams

Offices

Related companies